Warning letter
Novocol Pharmaceutical of Canada Inc.: warning letter of Jan 8, 1999
FDA warning letter UCM067036 · Center for Drug Evaluation and Research
Key facts
| Reference number | UCM067036 |
|---|---|
| Company | Novocol Pharmaceutical of Canada Inc. |
| Subject | CGMP Deviations |
| Issue date | Jan 8, 1999 |
| Posted date | Jan 8, 1999 |
| Issuing office | Center for Drug Evaluation and Research |
| Product type | Drugs |
| Country | 3 |
| Letter on fda.gov | web.archive.org |
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: